In the highly regulated pharmaceutical industry, the quality of raw materials is non-negotiable. For manufacturers of Dolutegravir and its sodium salt, securing a consistent supply of high-purity (4R,12aS)-7-Methoxy-4-methyl-6,8-dioxo-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxylic acid (CAS: 1335210-34-8) is a critical step in their production process. This complex organic molecule, with its specific stereochemistry and functional groups, demands precise synthesis and rigorous quality control.

When seeking to purchase this essential pharmaceutical intermediate, B2B buyers, including procurement managers and R&D scientists, prioritize suppliers who can guarantee both purity and reliability. The chemical formula C14H16N2O6 and molecular weight of 308.29 are just the starting points; the actual chemical properties and absence of impurities are what truly matter for downstream API synthesis. Therefore, identifying a manufacturer with a proven track record in producing high-purity chemicals is crucial.

As a dedicated manufacturer and supplier of pharmaceutical intermediates, we understand these demands. Our facility is equipped to produce (4R,12aS)-7-Methoxy-4-methyl-6,8-dioxo-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxylic acid with an assay of ≥98%, presented as a white to light yellow powder. We offer competitive pricing for bulk orders, and our robust supply chain ensures timely delivery to pharmaceutical companies worldwide. If you are looking for a trusted source for this intermediate, consider our commitment to quality and customer service.

We invite you to inquire about our product specifications, pricing, and our capabilities as a reliable chemical supplier. By choosing us, you gain a partner dedicated to supporting your pharmaceutical development and manufacturing objectives with high-quality intermediates and efficient logistics. Secure your supply chain and ensure the integrity of your Dolutegravir-based medications.